Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank86
3Y CAGR+56.1%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+56.1%/yr
vs -39.4%/yr prior
Acceleration
+95.5pp
Accelerating
Percentile
P86
Within normal range
vs 3Y Ago
3.8x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$47.68M+47.5%
2024$32.33M+86.7%
2023$17.32M+38.2%
2022$12.54M+166.8%
2021$-18.78M-0.0%
2020$-18.77M-116.1%
2019$116.59M+25.4%
2018$92.99M+137.2%
2017$-249.67M-66.1%
2016$-150.27M-